MMP9 and COVID-19: It has been recently shown that matrix metalloproteinase-9 (MMP-9) gene expression is increased in subjects infected with SARS-CoV-2 (18) and circulating MMP-9 levels were significantly associated with the risk of respiratory insufficiency (19) and with severity in COVID-19 patients (20).